Singapore markets closed

Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
120.07-3.20 (-2.60%)
At close: 04:02PM EST
120.30 +0.23 (+0.19%)
Pre-market: 08:58AM EST
Full screen
Trade prices are not sourced from all markets
Previous close123.27
Bid0.00 x 900
Ask0.00 x 800
Day's range119.00 - 121.68
52-week range105.36 - 142.60
Avg. volume5,948,162
Market cap217.976B
Beta (5Y monthly)0.70
PE ratio (TTM)29.79
EPS (TTM)4.03
Earnings date18 Apr 2022 - 22 Apr 2022
Forward dividend & yield1.88 (1.53%)
Ex-dividend date13 Jan 2022
1y target est144.58
  • Motley Fool

    Abbott Laboratories (ABT) Q4 2021 Earnings Call Transcript

    It cannot be recorded or rebroadcast without Abbott's expressed written permission. With me today are Robert Ford, chairman and chief executive officer; and Bob Funck, executive vice president, finance and chief financial officer. Abbott cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements.

  • Zacks

    Abbott's (ABT) Q4 Earnings and Revenues Beat Estimates

    Abbott's (ABT) COVID-19 testing-related sales in Q4 increased on demand for BinaxNOW, Panbio and ID NOW rapid testing platforms.

  • Zacks

    Abbott (ABT) Q4 Earnings and Revenues Surpass Estimates

    Abbott (ABT) delivered earnings and revenue surprises of 11.86% and 8.52%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?